Results 181 to 190 of about 35,988 (205)

EGFR- and Integrin α_Vβ₃-Targeting Peptides as Potential Radiometal-Labeled Radiopharmaceuticals for Cancer Theranostics. [PDF]

Int J Mol Sci
Rodrigues Toledo C, Tantawy AA, Lima Fuscaldi L, Malavolta L, de Aguiar Ferreira C.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Integrin αvβ6–TGFβ–SOX4 Pathway Drives Immune Evasion in Triple-Negative Breast Cancer

Cancer Cell, 2021
Archis Bagati, Peng Jiang, Jason Pyrdol   +2 more
exaly  

Cryo-EM Reveals Integrin-Mediated TGF-β Activation without Release from Latent TGF-β

Cell, 2020
Melody G Campbell, Anthony Cormier, Robert I Seed   +2 more
exaly  

The final steps of integrin activation: the end game

Nature Reviews Molecular Cell Biology, 2010
Sanford J Shattil, Chungho Kim, Mark H Ginsberg   +2 more
exaly  

Integrin-based therapeutics: biological basis, clinical use and new drugs

Nature Reviews Drug Discovery, 2016
Klaus Ley, Jesus Rivera-Nieves, William J Sandborn   +2 more
exaly  

Integrin's new partner

Nature Reviews Molecular Cell Biology, 2010
Kim Baumann
exaly